Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 120

1.

Food Insecurity, CKD, and Subsequent ESRD in US Adults.

Banerjee T, Crews DC, Wesson DE, Dharmarajan S, Saran R, RĂ­os Burrows N, Saydah S, Powe NR; CDC CKD Surveillance Team.

Am J Kidney Dis. 2017 Jul;70(1):38-47. doi: 10.1053/j.ajkd.2016.10.035. Epub 2017 Feb 16.

PMID:
28215947
2.

Cystinuria: current concepts and future directions.

Pereira DJ, Schoolwerth AC, Pais VM.

Clin Nephrol. 2015 Mar;83(3):138-46. Review.

PMID:
25685869
3.

Dietary acid load and chronic kidney disease among adults in the United States.

Banerjee T, Crews DC, Wesson DE, Tilea A, Saran R, Rios Burrows N, Williams DE, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

BMC Nephrol. 2014 Aug 24;15:137. doi: 10.1186/1471-2369-15-137.

4.

Estimating prevalence of CKD stages 3-5 using health system data.

Shahinian VB, Hedgeman E, Gillespie BW, Young EW, Robinson B, Hsu CY, Plantinga LC, Burrows NR, Eggers P, Saydah S, Powe NR, Saran R; CDC CKD Surveillance System.

Am J Kidney Dis. 2013 Jun;61(6):930-8. doi: 10.1053/j.ajkd.2013.01.018. Epub 2013 Mar 13.

5.

Americans' use of dietary supplements that are potentially harmful in CKD.

Grubbs V, Plantinga LC, Tuot DS, Hedgeman E, Saran R, Saydah S, Rolka D, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team.

Am J Kidney Dis. 2013 May;61(5):739-47. doi: 10.1053/j.ajkd.2012.12.018. Epub 2013 Feb 14.

6.

Nonsteroidal anti-inflammatory drug use among persons with chronic kidney disease in the United States.

Plantinga L, Grubbs V, Sarkar U, Hsu CY, Hedgeman E, Robinson B, Saran R, Geiss L, Burrows NR, Eberhardt M, Powe N; CDC CKD Surveillance Team.

Ann Fam Med. 2011 Sep-Oct;9(5):423-30. doi: 10.1370/afm.1302.

7.

Association of sleep-related problems with CKD in the United States, 2005-2008.

Plantinga L, Lee K, Inker LA, Saran R, Yee J, Gillespie B, Rolka D, Saydah S, Powe NR; CDC CKD Surveillance Team.

Am J Kidney Dis. 2011 Oct;58(4):554-64. doi: 10.1053/j.ajkd.2011.05.024. Epub 2011 Aug 4.

PMID:
21816524
8.

Multidisciplinary CKD care enhances outcomes at dialysis initiation.

Dixon J, Borden P, Kaneko TM, Schoolwerth AC.

Nephrol Nurs J. 2011 Mar-Apr;38(2):165-71.

PMID:
21520695
9.

Vulnerable populations and the association between periodontal and chronic kidney disease.

Grubbs V, Plantinga LC, Crews DC, Bibbins-Domingo K, Saran R, Heung M, Patel PR, Burrows NR, Ernst KL, Powe NR; Centers for Disease Control and Prevention CKD Surveillance Team.

Clin J Am Soc Nephrol. 2011 Apr;6(4):711-7. doi: 10.2215/CJN.08270910. Epub 2011 Feb 24.

10.

Association of CKD with disability in the United States.

Plantinga LC, Johansen K, Crews DC, Shahinian VB, Robinson BM, Saran R, Burrows NR, Williams DE, Powe NR; CDC CKD Surveillance Team.

Am J Kidney Dis. 2011 Feb;57(2):212-27. doi: 10.1053/j.ajkd.2010.08.016. Epub 2010 Oct 30.

11.

Validation of CKD and related conditions in existing data sets: A systematic review.

Grams ME, Plantinga LC, Hedgeman E, Saran R, Myers GL, Williams DE, Powe NR; CDC CKD Surveillance Team.

Am J Kidney Dis. 2011 Jan;57(1):44-54. doi: 10.1053/j.ajkd.2010.05.013. Epub 2010 Aug 6. Review.

12.

Does safe dosing of iodinated contrast prevent contrast-induced acute kidney injury?

Brown JR, Robb JF, Block CA, Schoolwerth AC, Kaplan AV, O'Connor GT, Solomon RJ, Malenka DJ.

Circ Cardiovasc Interv. 2010 Aug;3(4):346-50. doi: 10.1161/CIRCINTERVENTIONS.109.910638. Epub 2010 Jun 29.

13.

Prevalence of chronic kidney disease in persons with undiagnosed or prehypertension in the United States.

Crews DC, Plantinga LC, Miller ER 3rd, Saran R, Hedgeman E, Saydah SH, Williams DE, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Hypertension. 2010 May;55(5):1102-9. doi: 10.1161/HYPERTENSIONAHA.110.150722. Epub 2010 Mar 22.

14.

A health policy model of CKD: 1. Model construction, assumptions, and validation of health consequences.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative.

Am J Kidney Dis. 2010 Mar;55(3):452-62. doi: 10.1053/j.ajkd.2009.11.016. Epub 2010 Feb 8.

PMID:
20116911
15.

A health policy model of CKD: 2. The cost-effectiveness of microalbuminuria screening.

Hoerger TJ, Wittenborn JS, Segel JE, Burrows NR, Imai K, Eggers P, Pavkov ME, Jordan R, Hailpern SM, Schoolwerth AC, Williams DE; Centers for Disease Control and Prevention CKD Initiative.

Am J Kidney Dis. 2010 Mar;55(3):463-73. doi: 10.1053/j.ajkd.2009.11.017. Epub 2010 Feb 8.

PMID:
20116910
16.

Establishing a national chronic kidney disease surveillance system for the United States.

Saran R, Hedgeman E, Plantinga L, Burrows NR, Gillespie BW, Young EW, Coresh J, Pavkov M, Williams D, Powe NR; CKD Surveillance Team.

Clin J Am Soc Nephrol. 2010 Jan;5(1):152-61. doi: 10.2215/CJN.05480809. Epub 2009 Dec 3.

17.

Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis.

Brown JR, Block CA, Malenka DJ, O'Connor GT, Schoolwerth AC, Thompson CA.

JACC Cardiovasc Interv. 2009 Nov;2(11):1116-24. doi: 10.1016/j.jcin.2009.07.015. Review.

18.

Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999-2006.

Plantinga LC, Miller ER 3rd, Stevens LA, Saran R, Messer K, Flowers N, Geiss L, Powe NR; Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team.

Hypertension. 2009 Jul;54(1):47-56. doi: 10.1161/HYPERTENSIONAHA.109.129841. Epub 2009 May 26.

19.

Comprehensive public health strategies for preventing the development, progression, and complications of CKD: report of an expert panel convened by the Centers for Disease Control and Prevention.

Levey AS, Schoolwerth AC, Burrows NR, Williams DE, Stith KR, McClellan W; Centers for Disease Control and Prevention Expert Panel.

Am J Kidney Dis. 2009 Mar;53(3):522-35. doi: 10.1053/j.ajkd.2008.11.019.

PMID:
19231739
20.

Transient and persistent renal dysfunction are predictors of survival after percutaneous coronary intervention: insights from the Dartmouth Dynamic Registry.

Brown JR, Malenka DJ, DeVries JT, Robb JF, Jayne JE, Friedman BJ, Hettleman BD, Niles NW, Kaplan AV, Schoolwerth AC, Thompson CA.

Catheter Cardiovasc Interv. 2008 Sep 1;72(3):347-354. doi: 10.1002/ccd.21619.

PMID:
18729173

Supplemental Content

Loading ...
Support Center